SCHEMBL1964675

SCHEMBL1964675

CCOC(=O)c1cccc(Nc2ccc(OCCN(C)C)cc2OC)c1C(=O)O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDC25B P30305 2/20 0.46
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
HPGD P15428 1/20 0.44
TP53 P04637 2/20 0.43
MAPT P10636 2/20 0.43
KDM4E B2RXH2 4/20 0.42
APAF1 O14727 1/20 0.42
RECQL P46063 1/20 0.42
CASP6 P55212 1/20 0.42
CACNA1B Q00975 1/20 0.42
APBA1 Q02410 1/20 0.42
MCL1 Q07820 1/20 0.42
CASP8 Q14790 1/20 0.42
EGFR P00533 2/20 0.42
BTK Q06187 2/20 0.42
CDK4 P11802 1/20 0.42
CCND1 P24385 1/20 0.42
CDK6 Q00534 1/20 0.42
GAK O14976 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1961738 0.95 CDC25B (0.45) CDC25BMEN1KMT2AHPGDTP53
SCHEMBL1963248 0.93 CDC25B (0.44) CDC25BMEN1KMT2AHPGDTP53
SCHEMBL1962084 0.91 MEN1 (0.46) CDC25BMEN1KMT2AHPGDTP53
SCHEMBL1964177 0.90 BRPF1 (0.43) CDC25BMEN1KMT2AHPGDTP53
SCHEMBL1963479 0.87 CDC25B (0.54) CDC25BKMT2AHPGDTP53MAPT
SCHEMBL1964674 0.86 KDR (0.44) HPGDKDM4EAPAF1RECQLCASP6
SCHEMBL1964234 0.84 HRH3 (0.50) CDC25BMEN1KMT2AHPGDMAPT
SCHEMBL1962517 0.84 KMT2A (0.46) CDC25BMEN1KMT2AKDM4EALDH1A1
SCHEMBL1961839 0.83 KMT2A (0.48) MEN1KMT2AKDM4EALDH1A1KDR
SCHEMBL1963639 0.83 CDC25B (0.49) CDC25BHPGDTP53MAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1919892-B1 ISOINDOLE-IMIDE COMPOUNDS AND COMPOSITIONS COMPRISING AND METHODS OF USING THE SAME CELGENE CORP (US) 2013-08-14 EP disclosed
US-8481568-B2 Isoindole-imide compounds and compositions comprising and methods of using the same CELGENE CORPORATION (US) 2013-07-09 US disclosed
US-20110144158-A1 ISOINDOLE-IMIDE COMPOUNDS AND COMPOSITIONS COMPRISING AND METHODS OF USING THE SAME SEPRACOR INC. 2011-06-16 US disclosed
EP-1919892-A2 ISOINDOLE-IMIDE COMPOUNDS AND COMPOSITIONS COMPRISING AND METHODS OF USING THE SAME CELGENE CORPORATION (US) 2008-05-14 EP disclosed
WO-2007027527-A2 ISOINDOLE-IMIDE COMPOUNDS AND COMPOSITIONS COMPRISING AND METHODS OF USING THE SAME CELGENE CORPORATION (US) 2007-03-08 WO disclosed
US-20070049618-A1 Isoindole-imide compounds and compositions comprising and methods of using the same CELGENE CORPORATION 2007-03-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110144158-A1 ISOINDOLE-IMIDE COMPOUNDS AND COMPOSITIONS COMPRISING AND METHODS OF USING THE SAME SI, CYP3A5, CYP2D6 CDC25B 420/4885MEN1 907/4885KMT2A 4292/4885
US-20070049618-A1 Isoindole-imide compounds and compositions comprising and methods of using the same SI, CYP3A5, CYP2D6 CDC25B 420/4885MEN1 907/4885KMT2A 4292/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.